Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 994 entries
View as:

Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02346877 Org: User:
Start: 04/30/15 End: 10/31/15 Due: 10/31/16

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00361634 Org: User:
Start: 09/30/06 End: 03/31/10 Due: 03/31/11

Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00111098 Org: User:
Start: 03/31/04 End: 11/30/05 Due: 11/30/06

Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT)

Phase: N/A Priority: Normal
NCT ID: NCT03776058 Org: User:
Start: 06/15/00 End: 12/26/00 Due: 12/26/01

Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01732783 Org: User:
Start: 12/10/12 End: 11/30/16 Due: 11/30/17

Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01666977 Org: User:
Start: 08/31/12 End: 11/30/15 Due: 11/30/16

A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05073315 Org: User:
Start: 10/04/21 End: 12/19/22 Due: 12/19/23

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01868997 Org: User:
Start: 07/31/13 End: 02/22/17 Due: 02/22/18

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT05322577 Org: User:
Start: 05/17/22 End: 04/01/28 Due: 04/01/29

Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03410056 Org: User:
Start: 05/22/18 End: 05/13/20 Due: 05/13/21

A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium

Phase: N/A Priority: Normal
NCT ID: NCT03096990 Org: User:
Start: 04/21/17 End: 12/27/18 Due: 12/27/19

Chart Review of Repatha® in Subjects With Hyperlipidaemia

Phase: N/A Priority: Normal
NCT ID: NCT02770131 Org: User:
Start: 05/04/16 End: 06/30/21 Due: 06/30/22

Study to Evaluate the Safety and Tolerability of AMG 986 in Healthy Volunteers and Heart Failure Patients

Phase: N/A Priority: Normal
NCT ID: NCT03276728 Org: User:
Start: 08/12/16 End: 04/18/19 Due: 04/18/20

Darbepoetin Alfa MDS Companion Protocol

Phase: N/A Priority: Normal
NCT ID: NCT02175277 Org: User:
Start: 06/12/14 End: 03/20/17 Due: 03/20/18

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00111449 Org: User:
Start: 06/30/03 End: - Due: -

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00118638 Org: User:
Start: 03/31/04 End: 01/31/05 Due: 01/31/06

A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density

Phase: N/A Priority: Normal
NCT ID: NCT00293813 Org: User:
Start: 05/31/06 End: 08/31/08 Due: 08/31/09

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00583674 Org: User:
Start: 12/31/07 End: 06/30/12 Due: 06/30/13

Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00115193 Org: User:
Start: 02/28/03 End: 08/31/05 Due: 08/31/06

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Phase: N/A Priority: Normal
NCT ID: NCT03299244 Org: User:
Start: 05/15/18 End: 04/08/20 Due: 04/08/21

Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00102830 Org: User:
Start: - End: - Due: -

Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02345408 Org: User:
Start: 02/28/15 End: 05/06/20 Due: 05/06/21

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT06295679 Org: User:
Start: 12/19/22 End: 12/19/28 Due: 12/19/29

Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study-2

Phase: N/A Priority: Normal
NCT ID: NCT01763918 Org: User:
Start: 02/07/13 End: 12/19/13 Due: 12/19/14

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT00614523 Org: User:
Start: 07/21/08 End: 11/30/15 Due: 11/30/16